Interferon-gamma treatment to improve efficacy of hematopoietic stem cell transplantation for AML and other cancer

— Technology Description

Researchers at Washington University in St. Louis have discovered that interferon-gamma treatment could potentially prevent relapse after hematopoietic stem cell transplantation (HCT) treatment by making the cancer cells more visible to the donor immune cells. This technolog…

Biomarker to predict cancer response to chemotherapy

— Technology Description

Researchers at Washington University in St. Louis have developed a prognostic biomarker that can be used to predict response to genotoxic chemotherapy for patients with basal-like/triple-negative breast cancer. Basal-like/triple-negative breast cancer is considered to be mor…

Create a Collection
Creating...